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All 302 neurons in the C. elegans hermaphrodite arise through asymmetric division of neuroblasts.
During embryogenesis, the C. elegans ham-1 gene is required for several asymmetric neuroblast divisions
in lineages that generate both neural and apoptotic cells. By antibody staining, endogenous HAM-1 is
found exclusively at the cell cortex in many cells during embryogenesis and is asymmetrically localized in
dividing cells. Here we show that in transgenic embryos expressing a functional GFP::HAM-1 fusion
protein, GFP expression is also detected in the nucleus, in addition to the cell cortex. Consistent with the
nuclear localization is the presence of a putative DNA binding winged-helix domain within the N-ter-
minus of HAM-1. Through a deletion analysis we determined that the C-terminus of the protein is re-
quired for nuclear localization and we identiﬁed two nuclear localization sequences (NLSs). A subcellular
fractionation experiment from wild type embryos, followed by Western blotting, revealed that en-
dogenous HAM-1 is primarily found in the nucleus. Our analysis also showed that the N-terminus is
necessary for cortical localization. While ham-1 function is essential for asymmetric division in the
lineage that generates the PLM mechanosensory neuron, we showed that cortical localization may not
required. Thus, our results suggest that there is a nuclear function for HAM-1 in regulating asymmetric
neuroblast division and that the requirement for cortical localization may be lineage dependent.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
Asymmetric cell division is essential for the generation of cel-
lular diversity and the self-renewal of stem cells. The process by
which a mother cell divides to generate two daughter cells with
distinct cell fates relies on a series of coordinated events. Asym-
metrically dividing cells must establish an axis of polarity and
asymmetrically localize intrinsic factors including cell fate de-
terminants. The correct orientation and positioning of the mitotic
spindle is necessary to ensure the unequal segregation of cell fate
determinants into the daughter cells upon division.
A wealth of knowledge has emerged from the study of asym-
metric neuroblast division in the Drosophila CNS. CNS neuroblasts
are polarized along the apical-basal axis and divide asymme-
trically to generate a larger self-renewing neuroblast and a smaller
ganglion mother cell (GMC). The GMC then divides to produce two
neurons or glia cells. Many intrinsically localized factors have been
identiﬁed that are required for this asymmetric division (reviewedin Knoblich, 2008, 2010; Prehoda, 2009). On the apical cortex of
the neuroblast the adapter protein Inscuteable (Insc) binds two
evolutionarily conserved apical protein complexes, the Par3/Par6/
atypical protein kinase C (aPKC) complex and a second complex
consisting of proteins involved in heterotrimeric G-protein sig-
naling, Gαi/Partner of Inscuetable(Pins)/Mud. The Par3 complex
mediates the localization of the basal cell fates determinants
Prospero (Pros), Brain Tumor (Brat) and Numb and their adapter
proteins Miranda and Partner of Numb (Pon). The G-protein sig-
naling complex mediates alignment of the mitotic spindle along
the apical basal axis and displacement of the spindle towards the
basal side to ensure that the segregation of the basal cell fate
determinants into the smaller GMC.
In C. elegans by contrast, although all 302 neurons are gener-
ated from asymmetric cell divisions, little is known about intrinsic
factors controlling asymmetric neuroblast division. While both
apically localized complexes found in Drosophila CNS neuroblasts
are conserved in C. elegans, they have been shown to regulate the
asymmetric division of the one cell zygote (Etemad-Moghadam
et al., 1995; Gotta and Ahringer, 2001; Gotta et al., 2003; Hung and
Kemphues, 1999; Srinivasan et al., 2003; Tabuse et al., 1998).
Neither complex has been implicated later during development in
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tains a Numb homolog, num-1, which functions as a negative
regulator of endocytosis but has no role in asymmetric neuroblast
division (Nilsson et al., 2008).
HAM-1 was the ﬁrst asymmetrically localized protein identiﬁed
in C. elegans speciﬁcally required for asymmetric neuroblast divi-
sion. At least 11 embryonic neuroblast lineages and two post-
embryonic lineages require HAM-1 function (Frank et al., 2005;
Guenther and Garriga, 1996; Doitsidou et al., 2008; Feng et al.,
2013). In addition to neurons, these lineages all produce at least
one apoptotic cell. The requirement for ham-1 has been char-
acterized in the asymmetric division of the embryonic HSN/PHB
neuroblast and the postembryonic division of the Q.a neuroblast
(Guenther and Garriga, 1996; Frank et al., 2005; Feng et al., 2013).
In wild type, division of both neuroblasts results in a smaller
anterior daughter cell that undergoes apoptosis and a larger pos-
terior daughter cell, either an HSN/PHB neuronal precursor or an
A/PQR neuron respectively. In ham-1 mutants, the asymmetric
neuroblast division is disrupted resulting in the transformation of
the anterior daughter into a second posterior-like daughter thus
leading to neuronal duplications (Guenther and Garriga, 1996;
Frank et al., 2005). The asymmetry in daughter cell size is also
affected. In ham-1 mutants, the HSN/PHB neuroblast cleavage
plane is displaced posteriorly resulting in a larger anterior
daughter cell that often inappropriately survives and a smaller
posterior daughter cell (Frank et al., 2005). A similar cell size
asymmetry phenotype was observed in the division of the Q.a
neuroblast. In wild type, Q.aa is half the size of Q.ap, while in a
ham-1 mutant Q.aa and Q.ap were of similar sizes or the anterior
daughter cell was larger (Feng et al., 2013).
The mechanism by which HAM-1 regulates asymmetric divi-
sion remains to be elucidated. By antibody staining, the protein is
observed during embryogenesis at the cell cortex in many cells
and is asymmetrically localized in dividing cells (Frank et al., 2005;
Guenther and Garriga, 1996). Using a HAM-1::GFP transgene, GFP
ﬂuorescence is detected in the Q.a nucleus and in both the Q.aa
and Q.ap daughter cells, but no fusion protein was detected at the
cell cortex. By antibody staining, endogenous protein has never
been detected in nuclei. Speciﬁcally, in the HSN/PHB neuroblast,
HAM-1 is asymmetrically localized to the posterior cortex and is
inherited by the HSN/PHB precursor, the cell whose fate is not
affected in a ham-1 mutant (Guenther and Garriga, 1996). This
localization pattern, coupled with the reversal in anterior and
posterior daughter cell sizes in ham-1 mutants, led to a model
suggesting that HAM-1 may function to position the mitotic
spindle in dividing neuroblasts (Frank et al., 2005). Further insight
into ham-1 function comes from an analysis of Q.a division. In the
asymmetric division of Q.a, the mitotic spindle is initially posi-
tioned in the center of the cell. An accumulation of NMY-2, a non-
muscle myosin, at the anterior cortex during cytokinesis is then
hypothesized to contribute to a smaller anterior daughter cell (Ou
et al., 2010). In a ham-1 mutant, a combination of symmetrical
myosin distribution and posterior displacement of the mitotic
spindle likely contributes to the affects on daughter cell size (Feng
et al., 2013). The ensuing cell fate transformations could then be a
secondary consequence of inappropriately inheriting asymme-
trically localized cell fate determinants whose localization is in-
dependent of HAM-1. However, this does not rule out a role for
HAM-1 in also directly regulating daughter cell fate.
Until recently, the HAM-1 sequence has provided little insight
into its function. Even though HAM-1 is associated with the cell
cortex, it contains no transmembrane domains or lipid-attachment
sites and has no sequence homology with other asymmetrically
localized proteins. It also does not contain any domains associated
with a scaffolding function. In this study, our goal was to gain
insight into the mechanism by which HAM-1 regulatesasymmetric neuroblast division through the identiﬁcation of se-
quences required for function and localization. Through a deletion
analysis we determined that the N-terminus is essential for loca-
lization to the cell cortex. However, through our analysis of ham-1
mutations that cluster in the N-terminus, we discovered that
cortical localization is potentially dispensable for asymmetric cell
division in the lineage that generates the PLM mechanosensory
neuron. Unexpectedly, we discovered that a functional GFP::HAM-
1 translation fusion protein localizes to the nucleus in addition to
the cell cortex. Consistent with this nuclear localization we iden-
tiﬁed two redundant nuclear localization sequences in the C-ter-
minus. Through a biochemical fractionation of embryonic extracts,
we showed for the ﬁrst time that endogenous HAM-1 is primarily
a nuclear localized protein. Because of the presence of a winged-
helix domain, a putative DNA binding domain, in combination
with the nuclear localization, we suggest that HAM-1 likely
functions as a transcriptional regulator to distribute develop-
mental potential during asymmetric cell division.2. Material and methods
2.1. Strains
Strains were grown and maintained at 20 °C as previously de-
scribed (Brenner, 1974). The following mutations and GFP arrays
were used for this study: ham-1(gm214), ham-1(gm267), ham-1
(gm279) (Frank et al., 2005), ham-1(n1811) (Guenther and Garriga,
1996), ham-1(cas27), ham-1(cas46), ham-1(cas137) (Feng et al.,
2013), ham-1(ot361) (Doitsidou et al., 2008), ced-4(n1162) (Ellis
and Horvitz, 1986), zdIs5(mec-4::gfp) (Clark and Chui, 2003), ncIs1
(eat-20::gfp) (Shibata et al., 2000).
2.2. Generation of constructs and transgenic animals
ham-1 constructs were generated in pPD118.15, a promoterless
gfp vector containing the let-858 3'UTR. The unc-119 promoter
sequence was PCR ampliﬁed from the plasmid pBY103 (provided
by Morris Maduro) with Phusion High-Fidelity DNA polymerase
(New England Biolabs) using primers unc119-1 (5′CATGTCTA-
GAAAGCTTCAGTAAAAGAAGTAGAATTTTATAG3′) and unc119-2 (5′
CGATGGTACCCCGTGGAGATCTTATCGATAATGG3′) containing XbaI
and Kpn1 restriction sites respectively. The 1.2 kb promoter se-
quence was subcloned into the XbaI and Kpn1 sites of pPD118.15
generating pAL13. The full length ham-1 open reading frame (bp
1-1245) was ampliﬁed from plasmid PH1 (provided by Gian Gar-
riga) using primers hm69 (GTACGAATTCATGACCTACT-
TAGCCGTTGTGC) and hm70 (GACTGAATTCCTACAAATTGGA-
GATCAGGACGC) containing EcoRI restriction sites and inserted
downstream of gfp into the EcoRI site of pAL13 to generate
pNH144. A series of ham-1 deletion constructs were created by
PCR ampliﬁcation and subcloning into the EcoRI site of pAL13
generating pNH150 (bp 1-1093), pNH151 (bp 1–804), pNH152 (bp
1–505), pNH153 (bp 1–198), pNH154 (bp 94–1245), pNH155 (bp
340–1245), pNH156 (bp 628–1245) and pNH157 (bp 937–1245).
Mutation of the nuclear localization sequences and the putative
SH3 binding motif were created by site-directed, ligase-in-
dependent mutagenesis (SLIM) using pNH144 as template with
minor modiﬁcations (Chui et al., 2004). Two independent PCR
reactions were set-up with primers pairs FTþRS and FSþRT re-
spectively. Primer sequences are available upon request. After
ampliﬁcation, the PCR mixtures were pooled and digested with
DpnI. The remaining DNA duplexes were then denatured, re-
annealed and transformed into DH5α. All constructs were veriﬁed
by sequencing.
All ham-1 constructs were injected into zdIs5(mec-4::gfp) at a
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(Cordes et al., 2006) as a co-injection marker. Integrations were
carried out as previously described (McKay et al., 2003). Animals
carrying integrated transgenes were backcrossed six times to wild
type.
2.3. Feeding RNA interference
Feeding RNAi was performed essentially as described (Tim-
mons et al., 2001). L4 hermaphrodites were plated onto RNAi
plates and transferred to fresh plates every 24 h. Embryos from the
24–48 h plate were analyzed. The xpo-1 feeding RNAi construct
was obtained from the Ahringer RNAi library and veriﬁed by se-
quencing (Kamath and Ahringer, 2003). Empty vector, L4440, was
used as a control.
2.4. Nuclear-cytoplasmic fractionation and Western blotting
Embryos were isolated from gravid hermaphrodites by hypo-
chlorite treatment and washed several times with water. 500 μl of
packed embryos were resuspended in 3 mls of Sucrose Buffer 0
(0.176 M sucrose, 3 mM CaCl2, 2 mM magnesium acetate, 0.1 mM
EDTA, 10 mM Tris-Cl pH 8.0, 0.5% NP-40, 1 mM DTT, protease in-
hibitor) and homogenized for 30 strokes in a pre-cooled 7 ml
Wheaton stainless steel homogenizer with a stainless steel pestle
until approximately 80% of the embryos were broken. 500 μL of
the homogenate (total fraction) was removed and kept on ice. The
remaining 2.5 mls of homogenate was transferred to a 7 ml glass
dounce homogenizer and homogenized with a tight pestle for ﬁve
strokes. The homogenate was transferred to a 15 mL falcon tube
and centrifuged at 200 g for 30 s in a table top centrifuge to
pellet unbroken embryos. The supernatent was transferred to a
fresh tube and this step was repeated twice to ensure there were
no unbroken embryos remaining in the homogenate. 2 mls of
Sucrose buffer 2 (2 M sucrose, 3 mM CaCl2, 2 mM magnesium
acetate, 0.1 mM EDTA, 10 mM Tris-Cl pH 8.0, 1 mM DTT, protease
inhibitor) was added to 2 mls of the homogenate and 1 ml aliquots
were layered over 550 ul of Sucrose buffer 2 in 2.2 mL ultra-
centrifuge tubes (Thermo Fisher Polyclear tubes 45315) for a total
of four tubes. Finally, 100 μL of Sucrose Buffer 1 (0.32 M Sucrose,
3 mM CaCl2, 2 mM magnesium acetate, 0.1 mM EDTA, 10 mM Tris-
Cl pH 8.0, 0.5% NP-40, 1 mM DTT, protease inhibitor) was layered
on top of each tube and the tubes were centrifuged at 30,000 g
at 4 °C for 45 min in a Beckman TLS-55 rotor. The supernatent
(cytoplasmic fraction) was removed and each pellet (nuclear
fraction) was resuspended in 1 ml of Sucrose buffer 1 and com-
bined in a 15 ml falcon tube. The nuclear fraction was centrifuged
at 800 g using a swinging bucket rotor in a table top centrifuge.
The pellet was then gently washed three times with 10 mls of
Sucrose Buffer 1. After the last wash the pellet was resuspended in
250 μL of Sucrose 1 buffer. The protein in the nuclear and cytosolic
fractions, as well as the total cell extract, was concentrated by TCA
precipitation, and the protein resuspended in 2X SDS sample
buffer (10% SDS, 80 mM Tris pH 6.8, 12.5% Glycerol, 4% β-mer-
captoethanol) without bromophenol blue. Protein was quantitated
using the RC DC Protein assay kit (BioRad). For Western blotting
equivalent amounts of protein were loaded for all fractions. Pri-
mary antibodies used: anti-GAPDH antibody (1:1000) (Sigma
G8795), anti-Nuclear Pore Complex antibody (1:500) (Abcam
ab24609) and mouse anti-HAM-1 (1:25) (Guenther and Garriga,
1996).
2.5. Antibody staining and microscopy
Antibody staining of embryos was done as described previously
using afﬁnity puriﬁed rabbit anti-HAM-1 primary antibody (1:500)or anti-GFP primary antibody (1:1000) (Abcam) and Alexa Fluor
568 donkey anti-rabbit secondary antibody (1:1000) (Invitrogen)
(Frank et al., 2005). Stained embryos were mounted in DABCO
(0.1 g/ml DABCO in 1 PBS and 90% glycerin), while live embryos
were mounted in M9 on 5% agar pads and examined on a WaveFX
Spinning Disc Confocal Microscope system (Quorum Technologies,
Guelph ON). Images were captured with a Hammamatsu 9100-13
EMCCD digital camera. For GFP imaging of live embryos, laser
power (70%), camera sensitivity (100) and exposure time (1 s)
were kept constant during all z-stack acquisitions. Image acquisi-
tion was carried out using the Volocity software package (Perkin-
Elmer, Waltham, MA). All image processing was done using Adobe
Photoshop CS6, and all images within each ﬁgure were processed
identically. To obtain a semi-quantitative measurement of GFP
expression levels for each extrachromosomal array, mean pixel
intensity for multiple embryos was determined using the Volocity
Quantiﬁcation module. Expression levels of all the embryos ana-
lyzed were within 75%, or more, of the levels of hkIs39(unc-119p:
GFP::HAM-1) with the exception of hkEx153 and hkEx154 (see
Results)3. Results
3.1. HAM-1 is required for asymmetric cell division in the lineage
that generates the PLM and ALN neurons
In ham-1 mutants, asymmetric division defects of the HSN/PHB
neuroblast and Q.a have been well characterized (Frank et al.,
2005; Guenther and Garriga, 1996; Feng et al., 2013). Additional
neuronal duplications have implicated HAM-1 in many other
asymmetric neuroblast divisions during embryogenesis (Frank
et al., 2005; Guenther and Garriga, 1996). However, an exception
to neuronal duplications was observed in the lineage that gen-
erates the mechanosensory neuron PLM. Previously, using the
mec-4::GFP transgene zdIs5 to detect PLM neurons, penetrant PLM
losses were observed. (Cordes et al., 2006). This reporter is ex-
pressed in the six touch sensory neurons, and in early L1s, PLM is
the only GFP-expressing cell in the tail (Clark and Chiu, 2003).
Therefore, to extend our analysis of ham-1 function in asymmetric
neuroblast division we further characterized the role of ham-1 in
the PLM lineage. In the ham-1 null mutant, gm279, we have con-
ﬁrmed an 81% PLM neuronal loss using zdIs5 (Fig. 1B). There are
several positions within the lineage that generates PLM in which a
cell fate transformation could account for the loss of PLM neurons
(Fig. 1A). To determine if the PLMs neurons were adopting the fate
of their sister cells the ALN neurons, ALN neurons were visualized
with the GFP reporter ncIs1(eat-20::gfp). In ham-1(gm279) mu-
tants, the ALNs were also frequently missing (67% loss; N¼116).
Thus, the PLM neuron is not being transformed into its sister cell
the ALN neuron. Instead, the loss of neurons is likely due to an
asymmetric division defect at an earlier point in the lineage. The
divisions at both 295 and 395 minutes generate an apoptotic cell
(Fig. 1A). An asymmetric division defect at either of these divisions
could result in a cell transformation that would generate a second
apoptotic cell resulting in the loss of both the PLM and ALN neu-
rons. Therefore, we determined whether the loss of PLM neurons
could be suppressed by inhibiting programmed cell death using a
ced-4 mutant. ced-4, which is required for all programmed cell
deaths in C. elegans, encodes an Apaf1-like protein that is required
for the activation of the caspase CED-3 (Ellis and Horvitz, 1986;
Yuan and Horvitz, 1992; Zou et al., 1997). In a ced-4mutant alone, a
23% PLM duplication was observed indicating that the surviving
cell can occasionally express a PLM marker (Fig. 1B). Remarkably,
the 81% PLM loss observed in ham-1(gm279) animals was sup-
pressed to only a 10% loss in a ced-4 mutant (Fig. 1B). This result
Fig. 1. HAM-1 encodes a protein with a winged helix domain and is a negative regulator of cell death in the PLM/ALN lineage. (A) Embryonic lineage for the PLM and ALN
neurons. (B) PLM neuronal losses in ham-1(gm279) are suppressed by ced-4(n1162) and rescued with the punc-119::GFP::HAM-1 extrachromosomal arrays, hkE 42 and
hkE 43 and the integrated array hkIs39, *Po0.001, Fisher's exact test two-tailed. The mec-4::gfp reporter, zdIs5, was used to detect the PLM neurons. (C) Alignment of the
N-terminus of HAM-1 with Drosophila Knockout and human STOX-1. The winged helix domain is indicated with a black line above the corresponding sequence.
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death and that there is likely an asymmetric division defect at
either 295 or 395 minutes in the PLM/ALN lineage. In addition,
because ced-4 can suppress the PLM losses in a ham-1mutant, this
indicates that ham-1 is not directly required for PLM cell fate.
To precisely pinpoint which division in the PLM/ALN lineage is
disrupted in a ham-1 mutant we undertook a lineage analysis. We
predict that both daughter cells arising from either the 295 or 395
minute division would undergo apoptosis. No defects were ob-
served at the 295′ division. The division produced a single apop-
totic corpse of the correct size, in the correct location and at the
correct time (N¼15). In contrast, defects were apparent at the
later division. In wild type, the apoptotic corpse becomes visible at
the 1.5 fold stage of embryogenesis, a point in development in
which muscle contractions begin. In ham-1 mutants, we observed
this corpse in 7/16 lineages examined, but the appearance of this
corpse was always signiﬁcantly delayed, appearing toward the
two-fold stage of embryogenesis. We did not observe this corpse
in 9/16 lineages examined. However, we were unable to follow the
lineage past the two-fold stage of embryogenesis due to rapid
embryonic movements. This delay in cell death is similar to the
cell death delay in the HSN/PHB lineage in ham-1 mutants
(Guenther and Garriga, 1996). In addition, because we were unable
to follow this lineage past the two-fold stage of embryogenesis, wewere unable to determine if both daughter cells derived from the
395′ division eventually underwent apoptosis. However, our
lineage results in combination with the suppression of PLM losses
by a ced-4 mutation, strongly suggest an asymmetric defect at the
395′ division. We propose that the anterior daughter cell is
transformed into a second posterior-like cell resulting in the pro-
duction of two apoptotic daughter cells and the subsequent loss of
the PLM and ALN neurons.
3.2. HAM-1 encodes a putative DNA binding protein that localizes to
the nucleus
It was previously reported that HAM-1 encoded a 414 amino
acid protein with few homologs and no characterized domains.
The N-terminal region (amino acids 15–170) is 32% identical and
53% similar to the Drosophila protein Knockout (Frank et al., 2005;
Fig. 1C). More recently, the N-terminus of HAM-1 has also been
shown to be 33% identical and 57% similar to the human protein
STOX1, a member of the winged-helix protein family (van Dijk
et al., 2005) (Fig. 1C). To conﬁrm the presence of a winged-helix
domain in HAM-1 we performed a protein domain search using
InterProScan. A winged helix module was predicted between
amino acids 92–170 (Fig. 1C). These domains often mediate DNA
binding and STOX1 has been detected in both the nucleus and
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antibodies HAM-1 has only been detected at the cell cortex and
has not been observed in the nucleus (Frank et al., 2005; Guenther
and Garriga, 1996). Therefore, the functional signiﬁcance of the
winged-helix domain was not clear.
To understand how HAM-1 regulates asymmetric cell division
we wanted to further identify sequences responsible for both
HAM-1 function and localization. For these experiments, we ﬁrst
generated constructs in which GFP was fused to the N-terminus of
full length HAM-11-414. Since the ham-1 promoter has not been
identiﬁed, the unc-119 promoter was used to regulate expression.
UNC-119 expression begins at the 60-cell stage of embryogenesis
and is observed in many neural lineages, including many cells that
also express HAM-1 (Maduro and Pilgrim, 1995) (data not shown).
Transgenic animals expressing GFP::HAM-1 were assayed for the
ability of the transgene to rescue the ham-1(gm279) PLM neuronal
defect. In the presence of the extrachromosomal arrays expressing
the GFP::HAM-1 fusion protein, hkE42 and hkE 43, the loss of
PLM was reduced to 21% and 39% respectively (Fig. 1B). The in-
complete rescue of the PLM neuron may be attributed mosaicism
associated with extrachromosomal arrays. Therefore, hkE42 was
stably integrated into the genome. The integrated array, hkIs39,
reduced PLM loss to only 5% in a ham-1 null mutant, indicating
that this construct is functioncal (Fig. 1B). In addition, we observed
PLM duplications in both wild type and ham-1(gm279) animals
(Fig. 1B).
To examine the expression and subcellular localization of the
GFP::HAM-1 fusion protein, transgenic embryos were isolated and
immunostained with anti-GFP antibodies. The fusion protein wasFig. 2. GFP::HAM-1 localizes to both the cell periphery and in the nucleus. (A) A tra
transgenic embryo expressing GFP::HAM-1 examined directly for GFP ﬂuorescence. (C) W
with antibodies against GAPDH (a cytosolic marker), a nuclear pore complex (NPC) prot
seen in the nuclear fraction. Upon a longer exposure (LE), cytosolic HAM-1 is also detedetected primarily at the cell periphery with low levels in the
cytoplasm and asymmetric localization was clearly observed in a
subset of transgenic embryos (Fig. 2A). This is consistent with the
immunostaining pattern of endogenous HAM-1, though we did
not speciﬁcally assess the localization in the PLM lineage (Frank
et al., 2005; Guenther and Garriga, 1996). Localization of the GFP::
HAM-1 fusion protein was also assayed by direct GFP ﬂuorescence
in living embryos. While there was GFP ﬂuorescence at the cell
cortex, there was also strong ﬂuorescence detected in the nucleus
(Fig. 2B). However, when transgenic embryos from the same strain
are stained with either anti-GFP antibodies (from multiple sour-
ces), or afﬁnity puriﬁed anti- HAM-1 antibodies generated in ei-
ther mouse or rabbits, localization is detected primarily at the cell
cortex and very little if any staining is observed in the nucleus
(Fig. 2B; data not shown). This result strongly suggests that the
antibodies are ineffective at recognizing the GFP::HAM-1 protein
in the nucleus and may explain our inability to detect endogenous
HAM-1 in the nucleus.
To detect endogenous HAM-1 in the nucleus, we undertook an
embryonic subcellular fractionation experiment. N2 embryos were
isolated from gravid hermaphrodites and homogenized using a
metal dounce homogenizer, which was previously shown to dis-
rupt the eggshell while leaving the nuclei intact (Lichtsteiner and
Tjian, 1995). Nuclei were then puriﬁed by ultracentrifugation over
a sucrose cushion. The protein from the nuclear and cytoplasmic
fractions, as well as the total extract, was analyzed by Western
blotting (Fig. 2C). Immunoblotting for GAPDH (a cytoplasmic
marker) conﬁrmed the absence of cytoplasmic contamination in
the nuclear fraction, and there was very little nuclearnsgenic embryo expressing GFP::HAM-1 stained with anti-GFP antibodies. (B) A
estern blot analysis of total (T), nuclear (N) and cytoplasmic fractions from embryos
ein (nuclear marker) or HAM-1. In a short exposure (SE) for HAM-1, HAM-1 is only
cted. Scale bar 10 μm.
Fig. 3. The N-terminus of HAM-1 is necessary for association with the cell membrane (A) A schematic representation of HAM-1 deletion constructs that were tested for their
ability to rescue PLM neuronal defects and localization. (B–E) GFP ﬂuorescence of GFP::HAM-1 constructs in embryos. (B) hkE 105(GFP::HAM-132–414) (C) hkEx111
(GFP::HAM-1114–414) (D) hkEx117(GFP::HAM-1210–414) (E) hkE 121(GFP::HAM-1313–414). Scale bar 10 μm.
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antibody against a nuclear pore complex protein. Endogenous
HAM-1 was found predominantly in the nuclear fractionation,
with only a small of amount of HAM-1 detected in the cytoplasmic
fraction upon a longer exposure. This nuclear localization was
consistent with the ﬂuorescence observed in transgenic embryos
expressing GFP::HAM-1. Thus, this result unambiguously demon-
strates that endogenous HAM-1 is primarily a nuclear localized
protein.
3.3. Identiﬁcation of sequences required for localization and function
To identify sequences required for function and localization we
created a series of N- and C- terminal deletions (Fig. 3A). Function
was assessed by their ability to rescue the ham-1(gm279) PLM
neuronal defects. None of the truncations were capable of rescuing(Fig. 3A; Supplemental Table 1). There are several compelling ar-
guments that lack of rescue is not a consequence of expression
levels from the arrays. We integrated the extrachromosomal array,
hkE105(GFP::HAM-132–414) to generate hkIs40 and prepared
embryonic extracts from this strain and our rescuing GFP::HAM-1
line, hkIs39. By Western blot, expression levels of the two fusion
proteins are similar (data not shown). In addition, by confocal
microscopy, GFP expression levels between different array bearing
embryos were not signiﬁcantly different (see Materials and
Methods). Finally, since the shortest C-terminal truncation
(HAM-11–364) removed sequences deleted in a strong loss-of-
function ham-1 allele, gm214, which contains an in-frame 21
amino acid deletion in the C-terminus (Δ369–389), we did not
anticipate that this truncation would rescue. Therefore, both the
N-terminal 31 amino acids and the C-terminal 50 amino acids are
essential for function.
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transgenic embryos were directly observed for GFP ﬂuorescence.
Based on the nuclear fractionation experiment, direct GFP ex-
pression provides a more comprehensive pattern of localization.
Examination of the N-terminal truncations revealed that the
N-terminus is essential for association of HAM-1 to the cell cortex.
Deletion of the ﬁrst 31 amino acids (HAM-132–414) almost com-
pletely eliminated membrane association and the fusion protein
was detected in both the cytoplasm and nucleus (Fig. 3B). Occa-
sionally, weak membrane association was detected in a few cells.
This pattern of localization was not changed by further deleting
HAM-1 to amino acid 114 (HAM-1114–414); both cytoplasmic and
nuclear localization was observed (Fig. 3C). In contrast, the
C-terminal half of the protein (HAM-1210-414) is detected primarily
in the nucleus (Fig. 3D). Unlike full length GFP::HAM-1 and the
ﬁrst two N-terminal deletions, HAM-1210-414 is also readily de-
tected in the nucleus by staining with anti-GFP antibodies (data
not shown). Finally, the last 100 amino acids of HAM-1,
HAM-1313-414 is found throughout the cytoplasm and nucleus
(Fig. 3E). These results indicate that the N-terminus is essential for
membrane association and that there are sequences in the
C-terminal half of the protein required for nuclear localization.
Deletion of sequences from the C-terminal end also revealed
regions of the protein necessary for cortical association and nu-
clear localization. Deletion of the last 50 amino acids from the
C-terminus of HAM-1 (HAM-11–364) resulted in a clear reduction,
though not complete elimination, of cortically localized protein
and an enhancement in nuclear expression (Fig. 4A). This was
evident in an increase in GFP puncta in the nucleus. While puncta
in the nucleus are occasionally observed with the full length GFP::
HAM-1 fusion protein, there was an increase in nuclear puncta
with this deletion. Removal of a further 96 amino acids
(HAM-11–268) completely eliminated nuclear localization and the
protein is found exclusively at the cell membrane (Fig. 4B).Fig. 4. The C-terminus of HAM-1 contains sequences necessary for nuclear localization
hkE 66(GFP::HAM-11–364) (B) hkE88(GFP::HAM-11–268) (C) hkE 94(GFP::HAM-11–19Therefore, sequences between amino acid 268 and 364 of the
protein confer nuclear localization. Upon further deletion,
HAM-11–190 and HAM-11–168, the protein is no longer detected at
the membrane and now localizes to the cytoplasm and nucleus.
(Fig. 4C and D) These results indicate that sequences between
amino acids 190 and 268 also mediate membrane association.
While these further deletions may have uncovered a cryptic nu-
clear localization sequence that is masked in HAM-11–268, the
nuclear localization is more likely due to the small size of the fu-
sion proteins, 47 and 45 kD respectively. These sizes are just below
the limit for diffusion through nuclear pores. These truncated
proteins still retain the winged helix domain that might mediate
retention in the nucleus. Finally, we examined several transgenic
lines expressing only the N-terminal 66 amino acids, HAM-11–66.
All the lines were highly mosaic with very low levels of expression.
Regardless, only cytoplasmic and nuclear localization was ob-
served (data not shown). Together, these results show that in ad-
dition to the N-terminus of the protein, a region between 190 and
268 amino acids is necessary to confer membrane association.
Analysis of the HAM-1 protein sequence for functional motifs
using the ELM bioinformatics program predicted a series of proline
rich SH3 domain binding motifs located between amino acids 251
and 261 (PIHVGGPPTPP). This motif, which could mediate protein:
protein interactions, resides within the region identiﬁed by our
deletion analysis to contain sequences required for association
with the cell cortex. To test if this sequence contributed to HAM-1
localization we deleted amino acids 251–261 in the context of the
full-length protein (HAM-1Δ251–261) (Fig. 3A). Deletion of this se-
quence signiﬁcantly impaired the ability of HAM-1 to associate
with the cell cortex. In most embryos, the protein is no longer
observed at the cell periphery and is instead found in the cyto-
plasm and nucleus (Fig. 5A). Occasionally, an embryo is observed
with weak membrane staining still remaining (Fig. 5B). This con-
struct was also no longer able to rescue the PLM neuronal losses in. (A–D) GFP ﬂuorescence of the C-terminal GFP::HAM-1 deletions in embryos. (A)
0) (D) hkE 101(GFP::HAM-11-168). Scale bar 10 μm.
Fig. 5. An polyproline rich motif also mediates cortical association and is necessary
for function. (A) An early embryo expression GFP::HAM-1ΔSH3. Only nuclear loca-
lization is detected and the arrow highlights an increase in nuclear puncta. (B) The
dorsal side of a 260 minute embryo expressing GFP::HAM-1ΔSH3 in which very
weak membrane association is detected (arrow) (C) The GFP::HAM-1ΔSH3 transgene
hkE 211 fails to rescue ham-1(gm279) PLM neuronal defects. n.s. not signiﬁcant,
Fisher's exact test two-tailed. The mec-4::gfp reporter, zdIs5, was used to detect the
PLM neurons. Scale bar 10 μm.
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polyproline rich sequence is required for both function and loca-
lization to the cell cortex.
3.4. Cortical localization maybe dispensable for function
While deletion of the N-terminal 31 amino acids, and the
polyproline rich sequence both disrupted cortical localization and
abolished function, this result does not unequivocally demonstrate
that cortical localization is necessary for function. It is possible
that these deletions could affect protein function independent of
the localization defect. Therefore, we took advantage of several
different ham-1 mutations (Fig. 6A). It was previously shown by
antibody staining that ham-1(n1811) (G47D), completely disrupts
HAM-1 cortical localization and the protein is observed in the
cytoplasm (Frank et al., 2005) (Fig. 6G). While this mutation affects
asymmetric division in many neuronal lineages, we found that
there were only minor PLM losses (10%) (Fig. 6B). This unexpected
result suggests that HAM-1 cortical localization is not essential for
asymmetric division in the PLM lineage. Therefore, we assayed
additional ham-1 mutants for effects on HAM-1 localization and
PLM defects. ham-1(cas27), ham-1(cas46) and ham-1(cas137) were
isolated from a genetic screen for mutants with Q cell lineage
defects (Feng et al., 2013), while ham-1(gm214) and ham-1(gm267)
were isolated in a screen for HSN/PHB asymmetric division defects
(Frank et al., 2005). Several of these mutations cluster at the
N-terminus, a region of the protein that by our deletion analysis is
required for localization to the cortex (Fig. 6A). Both cas27 and
cas137 are missense mutations at amino acid 10 that change a
glycine into a charged amino acid; an arginine or glutamic acid
respectively. Both mutations result in delocalization of HAM-1
from the cell cortex (Fig. 6D,F). While cas27 results in complete
delocalization similar to n1811, there is still some weak membrane
association observed with cas137. gm267 is a missense mutation at
amino acid 58 that changes a glycine into an arginine and this also
results in a partial delocalization of HAM-1 from the cell cortex
(Fig. 6K). Surprisingly, every mutation that reduced or eliminated
membrane localization showed almost no defects in the PLM
lineage (Fig. 6B). Only ham-1(gm214), a small in frame 21 amino
acids deletion near the C-terminus also had penetrant defects in
the PLM lineage; a 69% loss of PLM neurons. In this case, by an-
tibody staining HAM-1 cortical localization was unaffected
(Fig. 6O) (Frank et al., 2005). These results suggest that cortical
localization is not essential for HAM-1 function in the PLM lineage.
3.5. Nuclear localization is controlled by two redundant nuclear lo-
calization sequences
Our analysis of the HAM-1 deletions indicated that a nuclear
localization signal (NLS) resides in the C-terminus of the protein
between amino acids 268–364. Using PSORTII, a computation tool
that predicts protein-sorting signals, a single NLS was predicted at
amino acids 321–327 (PTRRRAR) (Fig. 7A). To test the functional
relevance of this NLS, we deleted this sequence in the context of
full-length GFP::HAM-1 and analyzed localization of the protein in
transgenic embryos (HAM-1NLS1). Of the three transgenic lines
analyzed, hkE 169, displayed strong rescue of the PLM neuronal
defects similar to full-length GFP::HAM-1 (Fig. 7B). When locali-
zation of the fusion protein in hkE169 was analyzed by direct
GFP ﬂuorescence there was only a modest reduction of protein in
the nucleus and expression levels were comparable to our rescu-
ing GFP::HAM-1 fusion, hkIs39 (Fig. 7C). The other two lines,
hkE153 and hkE 154, showed only weak rescue with PLM
neuronal losses at 50% and 69% compared to 81% loss in ham-1
(gm279). However, expression from the other two arrays was
barely detectable (data not shown). This indicated, that when
Fig. 6. HAM-1 cortical localization is not necessary for function in the PLM lineage. (A) Schematic representation of the HAM-1 protein with the position of mutant alleles
and corresponding amino acid changes indicated. (B) Only the null allele, ham-1(gm279) as well as ham-1(gm214), an in-frame 21 amino acid deletion near the C-terminus,
display penetrant defects in the PLM lineage as assayed using the mec-4::gfp reporter zdIs5. (C–I) Confocal images of embryos stained with anti-HAM-1 antibodies and (C′–I′)
the corresponding DAPI images to detect nuclei. (C, I) In wild type and ham-1(gm214) embryos HAM-1 is detected at the cell cortex. (D,E) In ham-1(cas27) and ham-1(n811)
HAM-1 is completely delocalized from the cell cortex and is detected exclusively in the cytoplasm. (F, G and H) In ham-1(cas137), ham-1(gm267) and ham-1(ot361) there is a
variable reduction in cortically localized HAM-1 and an increase in cytoplasmic HAM-1 levels. Scale bar 10 μm.
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little impact on function and localization. This also suggested that
additional sequences contribute to nuclear localization. Since no
additional NLSs were predicted using PSORTII, we compared the C.
elegans HAM-1 protein sequence with the HAM-1 homologs from
two related Caenorhabditis species, C. remanei and C. briggsae. In
addition to the NLS already identiﬁed, PSORTII also predicted a bi-
partite NLS in the C. remanei and C. briggsae sequence (Fig. 7A). A
bipartite NLS consists of two basic residues followed by a 10 amino
acid spacer and a second basic region consisting of 3 out of 5 basic
residues. The C. elegans HAM-1 sequence contained only a portion
of this bi-partite NLS from amino acids 285–295
(RKARRRNHPRRG) (Fig. 7A). Therefore, we tested the requirement
for this second potential NLS sequence by mutating Lys 286 and
Arg 288–290 to Ala (HAM-1NLS2). Mutation of this sequence also
did not signiﬁcantly impair the ability of HAM-1 to rescue ham-1
(gm279). For the two extrachromosomal arrays tested, PLMneuronal losses were reduced to 54% and 43% respectively
(Fig. 7B). In addition, mutation of the second NLS alone had only
moderate effects on nuclear localization (Fig. 7D). Because muta-
tion of either NLS individually was not sufﬁcient to eliminate
nuclear localization, we mutated both NLSs simultaneously in
HAM-1. This resulted in localization of the fusion protein ex-
clusively to the cell cortex with little or no detectable nuclear lo-
calization (Fig. 7E). This pattern of localization was similar to the
C-terminally truncated protein HAM-11–268 that is lacking both
NLS sequences (Fig. 4B). Unexpectedly, function of this fusion
protein was unaffected. Of the ﬁve transgenic lines analyzed, all
showed robust rescue of the ham-1(gm279) PLM neuronal defects
(Fig. 7B). Defects were reduced from an 81% loss of PLMs in ham-1
(gm279) to only a 22% PLM loss in hkE 187 and hkE188. This
degree of rescue is on par with the extrachromosomal array ex-
pressing full length GFP::HAM-1, hkE 42 (Fig. 1B). Thus, nuclear
localization of HAM-1 is controlled by two partially redundant
Fig. 7. HAM-1 contains two partially redundant nuclear localization sequences. (A) An alignment of the C-terminus of HAM-1 from C. elegans (Ce) with the HAM-1 homologs
from C. remanei (Cr) and C. briggsae (Cb). NLS1 is identical in all three species, while a bipartite NLS, NLS2, is predicted by pSORTII in C. remanei and C. briggsae but several
amino acids separating the basic residues are absent in C. elegans. (B) Mutation of either NLS1, NLS2, or NLS1þNLS2 did not eliminate ability of GFP::HAM-1 to rescue the
PLM neuronal defects of ham-1(gm279). Po0.0001 for all the arrays except for hkE 153 where P¼0.0427, Fisher's exact test, two-tailed. (C) In embryos expressing
hkEx169(GFP::HAM-1NLS1), there is little reduction in nuclear localization (D) In embryos expressing hkEx180(GFP::HAM-1NLS2), there is a reduction but still detectable levels
of nuclear expression (E) Simultaneous mutation of both NLSs eliminates nuclear localization. Scale bar 10 μm.
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Fig. 8. GFP::HAM-1(NLS1þ2) ﬂuorescence is detected in the nucleus after nuclear export is blocked by xpo-1 RNAi. (A) In GFP::HAM-1 expressing embryos, GFP is detected in
the nucleus with occasional small nuclear puncta observed. (B) After xpo-1 RNAi to block nuclear export there is a dramatic accumulation of large nuclear GFP::HAM-1
puncta. (C) Mutation of both NLSs in GFP::HAM-1, GFP::HAM-1(NLS1þ2), eliminates nuclear localization. (D) Low levels of GFP::HAM-1(NLS1þ2) is observed in nuclei after xpo-
1 RNAi. Scale bar 10 μm.
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The rescuing ability of HAM-1 lacking both NLSs initially sug-
gested that nuclear localization might also be dispensable for
function. However, since we have demonstrated that cortical lo-
calization is likely not required for function in the PLM lineage,
and that the majority of HAM-1 is nuclear, we considered this
unlikely. Instead, we hypothesized that there is a low levels of
nuclear localized GFP::HAM-1(mutNLS1þ2) below our level of de-
tection that was sufﬁcient for rescue. Thus, we reasoned that we
could detect nuclear localized GFP::HAM-1(mutNLS1þ2) if we
blocked nuclear export. To block nuclear export we preformed
RNAi by feeding to knock down the function of the C. elegans
nuclear exportin homolog, XPO-1, and assayed the localization of
GFP::HAM-1 and GFP::HAM-1(mutNLS1þ2). In GFP::HAM-1 control
embryos, we occasionally saw puncta in the nuclei (Fig. 8A). In
xpo-1 RNAi embryos expressing GFP::HAM-1, we observed a
striking nuclear accumulation of protein in the form of large
puncta-like aggregates (Fig. 8B) suggesting that nuclear export is
regulated. When xpo-1 was knocked down in
GFP::HAM-1(mutNLS1þ2) embryos, low levels of nuclear localized
GFP::HAM-1(mutNLS1þ2) was consistently detected compared to
control embryos (Fig. 8C and D). Thus, this lends to support to our
contention that the rescuing ability of GFP::HAM-1(mutNLS1þ2) was
due to low levels of the protein in the nucleus.4. Discussion
We have provided compelling evidence, that in addition to
localization at the cell cortex, HAM-1 is also found in the nucleus.
A winged-helix domain related to the FOX family of transcription
factors is predicted near the N-terminus of HAM-1 (amino acids
92–170) (Fig. 1C; van Dijk et al., 2005). A winged helix domain is avariant of the helix-loop-helix DNA binding domain that in addi-
tion to three α-helices also possesses two loops that resemble
wings. HAM-1 displays the greatest degree of identity with the
human STOX1 protein. A polymorphism detected in STOX1 has
been proposed to contribute to a predisposition for preeclampsia,
pregnancy induced high blood pressure (van Dijk et al., 2005).
STOX1 is also abundantly expressed in the brain and expression
levels correlate with the severity of late onset Alzheimer's disease
(van Dijk et al., 2010). Besides the presence of a winged helix DNA
binding domain, several lines of evidence are consistent with
STOX1 functioning as a transcription factor. STOX1 has been
shown to localize to both the cytoplasm and nucleus in placental
cells and brain (van Dijk et al., 2005, 2010). In microarray experi-
ments, overexpression of STOX1 cell culture led to either tran-
scriptional repression or activation of 12.5% of genes detected on
the microarrays (Rigourd et al., 2008). Direct binding to the pro-
moter region of several genes has been conﬁrmed by chromatin
immunoprecipitation experiments (Rigourd et al., 2008; van Abel
et al., 2011, 2012; van Dijk et al., 2010). The similarity of the
winged helix domain between HAM-1 and STOX1 suggests that
HAM-1 may also function as a transcription factor (Feng et al.,
2013).
Although HAM-1 contains a putative DNA binding domain the
signiﬁcance of this homology is unclear. Previously, by antibody
staining, HAM-1 was detected at the cell cortex during embry-
ogenesis and staining in the nucleus had not been reported (Frank
et al., 2005; Guenther and Garriga, 1996). However, HAM-1::GFP
ﬂuorescence has been observed in the nuclei of the larval Q neu-
roblast daughter cells, Q.a. and Q.p., though no cortical localization
was detected (Feng et al., 2013). When we analyzed transgenic
embryos expressing a GFP::HAM-1 fusion we also observed strong
expression in the nucleus in addition to expression at the cell
cortex in living embryos. By contrast, once the transgenic embryos
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bodies only weak and variable nuclear localization was detected.
This result indicates that our antibodies are not effective in re-
cognizing nuclear GFP::HAM-1, and by extension, likely fail to
recognize endogenous HAM-1 in the nucleus. One possible ex-
planation is that the epitopes are masked in the nucleus due to
ﬁxation with paraformaldehyde, which induces protein cross-
links. Antigen retrieval techniques are often necessary to break-
down protein cross-links and allow antibodies accessibility to
nuclear antigens (Shi et al., 1997). Antigen masking may also be
the result in conformational changes in a protein or association
with other macromolecules that block antibody accessibility. Re-
gardless, this result led us to hypothesize that HAM-1 is also nu-
clear localized during embryogenesis.
We identiﬁed two NLSs in the C-terminus of HAM-1 that
function redundantly. Mutation of either NLS individually had only
modest effects on nuclear localization. Mutation of both NLSs si-
multaneously eliminated nuclear localization and this localization
pattern resembled the C-terminally truncated protein, HAM-11-268
where both sequences were deleted. The identiﬁcation of func-
tional NLSs provided further evidence that endogenous HAM-1 is
also a nuclear localized protein. In addition, a HAM-1::GFP protein
expressed under control of the endogenous promoter was shown
to localize exclusively to the nuclei of cells in L1 larvae (Feng et al.,
2013). However, nuclear localization had never been observed for
endogenous HAM-1. We wanted to rule out the possibility that
nuclear localization was a consequence of overexpression from our
integrated GFP::HAM-1 array. Therefore, to demonstrate that en-
dogenous HAM-1 was also nuclear localized we performed a
subcellular fractionation experiment from embryonic extracts
followed by Western blotting. This experiment conclusively de-
monstrated that the majority of endogenous HAM-1 is found in
the nucleus.
Although the vast majority of HAM-1 is nuclear localized, we
were surprised that mutation of both NLSs did not affect the
ability of the GFP::HAM-1(NLS1þ2) arrays to rescue . Thus, we in-
vestigated if there were residual levels of nuclear localized
GFP::HAM-1(NLS1þ2) below our level of detection, that was sufﬁ-
cient for rescue. When we blocked nuclear export by knockdown
of the C. elegans nuclear exportin homolog we observed
GFP::HAM-1(NLS1þ2) ﬂuorescence in the nucleus. This indicated
that mutation of both NLSs was not sufﬁcient to completely
abolish nuclear localization.
Because HAM-1 is predominantly localized to the nucleus, and
the homology to the transcriptional factor STOX-1, we propose
that HAM-1 functions in the nucleus to transcriptionally regulate
genes involved in asymmetric neuroblast division. Feng et al.
(2013) has previously proposed that HAM-1 functions as a tran-
scription factor during asymmetric division in the Q neuroblast
lineage. Because HAM-1 is speciﬁcally required in lineages that
produce both neurons and apoptotic cells we would expect that it
may regulate neural speciﬁcation genes and genes involved in
apoptosis. In addition, because HAM-1 also positions the cleavage
plane, it might directly regulate genes involved in this process.
One gene we would predict maybe directly regulated by HAM-1 is
pig-1, a Ser/Thr kinase that is homologous to the vertebrate Ma-
ternal Embryonic Leucine Zipper Kinase (MELK) (Cordes et al.,
2006). Like HAM-1, PIG-1 also regulates asymmetric division of
several neuroblasts that produce neurons and an apoptotic cell
and controls asymmetric positioning of the mitotic spindle. Unlike
HAM-1, PIG-1 is not asymmetrically localized during embryogen-
esis. Instead, it is uniformly localized in the cytoplasm throughout
the early embryo (Cordes et al., 2006). In the PLM lineage, a mu-
tation in pig-1 results in PLM duplications, while a ham-1 mutant
results in penetrant PLM losses. The pig-1; ham-1 double mutant
phenotype resembles that of pig-1 suggesting that ham-1 is anegative regulator of pig-1 (Cordes et al., 2006). Recent data sug-
gests that HAM-1 may bind to the promoter region of pig-1 (266
to 42 bp) (Feng et al., 2013). Deletion of this HAM-1 binding site
in the promoter of the Ppig-1::pig-1::gfp transgene resulted in loss
of GFP expression in the Q daughter cells (Feng et al., 2013). This
result is inconsistent with the genetic epistatsis experiment sug-
gesting ham-1 is a negative, not a positive regulator of pig-1.
However, the deleted region also contains an SP1 transcription
factor binding site that is required for pig-1 expression both em-
bryonically and post-embryonically (Hirose and Horvitz, 2013).
Therefore, further analysis will be necessary to deﬁne the role of
HAM-1 in pig-1 regulation and uncover the identity of additional
genes directly regulated by HAM-1.
We also identiﬁed at least two regions of the protein that are
both essential but not sufﬁcient for cortical localization. From our
deletion analysis we determined that the ﬁrst 31 amino acids of
HAM-1, upstream of the winged helix domain, are essential for
association of HAM-1 with the cell cortex. There are no obvious
domains or motifs in the N-terminus that would account for lo-
calization to the cell cortex. However, the N-terminal 190 amino
acids of HAM-1 alone were unable to confer membrane associa-
tion indicating the requirement for additional sequences. From our
analysis we also identiﬁed a polyproline rich sequence preceding
the ﬁrst NLS (aa 251-261) that was also essential but not sufﬁcient
for cortical localization. This sequence may function as a binding
motif for a protein containing a polyproline recognition domain
such as an SH3 or WW domain (Li, 2005). Deletion of either the
ﬁrst 31 amino acids, or the polyproline rich sequence completely
abolished function, which initially suggested that cortical locali-
zation may be necessary for HAM-1 function in the PLM lineage.
Alternatively, these deletions could disrupt function independent
of the localization defect. To unambiguously show that cortical
localization is required for function, it would be ideal to target the
deleted protein back to the cell cortex and show that function is
reestablished. Therefore, we fused a myristolylation sequence to
the N-terminus of GFP::HAM-1. Unfortunately, this completely
eliminated the function of the wild type GFP::HAM-1 fusion pro-
tein (data not shown) and thus was not a viable approach to target
the deleted proteins back to the cell cortex. Thus, we turned our
analysis to ham-1 mutants. Consistent with our deletion analysis,
previous work has demonstrated that sequences in the N-termi-
nus are important for cortical localization (Guenther and Garriga,
1996). ham-1(n1811) is a point mutation in amino acid 47 that
results delocalization of the protein from the cell cortex. While
ham-1(n1811) has defects in many neuronal lineages resulting in
neuronal duplications, we discovered only a very low penetrance
of PLM neuronal losses. When we expanded our analysis we found
that several additional mutations in the N-terminus also resulted
in a signiﬁcant or complete disruption of HAM-1 at the cell cortex.
Like ham-1(n1811), these mutants had virtually no PLM neuronal
defects. The only mutant examined, that in addition to the null
allele ham-1(gm279), which resulted in penetrant PLM neuronal
losses was ham-1(gm214). This allele results in an in-frame 21
amino acid deletion near the C-terminus. However, HAM-1 cortical
localization was normal. Therefore, we concluded that cortical
localization is likely not essential for asymmetric cell division in
the PLM lineage. However, we cannot rule out the formal possi-
bility that there is still residual cortical localization below our level
of detection in ham-1(n1811) and ham-1(cas27). In addition, the
possibility that HAM-1 localization in the PLM lineage is different
cansnot be ruled out.
While cortical localization is not required for asymmetric di-
vision in the PLM lineage, the mutant alleles that disrupt cortical
localization have penetrant defects in other neuronal lineages
(Doitsidou et al., 2008; Feng et al., 2013; Frank et al., 2005;
Guenther and Garriga, 1996). In ham-1 mutants, all the affected
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lineages previously examined, except for the PLM/ALN lineage, loss
of ham-1 function primarily produces neuronal duplications. These
neuronal duplications could be explained by an asymmetric divi-
sion defect, which allowed for the survival and differentiation of
an apoptotic cell. In this respect, HAM-1 could be considered to
have a pro-apoptotic function. In contrast, neuronal losses are
observed in the PLM/ALN lineage indicating that in this particular
lineage HAM-1 has a pro-survival function. Thus, it is tempting to
speculate that cortical localization may contribute to a pro-apop-
totic function of HAM-1. However, because expression of our GFP::
HAM-1 fusion protein was under control of a heterologous pro-
moter (unc-119), and resulted in a dominant overexpression phe-
notytpe (PLM duplications), we were unable to reliably assess
HAM-1 localization in the PLM lineage.
In most lineages, localization at the cell cortex maybe also be a
mechanism to regulate HAM-1 trafﬁcking to the nucleus to tran-
scriptionally regulate target genes. The only other transcription
factor described thus far that is asymmetrically localized at the cell
cortex during asymmetric neuroblast division is Pros, a home-
odomain containing protein. During asymmetric division of Dro-
sophila CNS neuroblasts, Pros is asymmetrically localized to the
basal cortex by the adapter protein Miranda and inherited by the
GMC upon division (Hirata et al., 1995; Ikeshima et al., 1997;
Knoblich et al., 1995; Schuldt et al., 1998; Shen et al., 1997, 1998;
Spana and Doe, 1995). Immediately after division, Miranda rapidly
disappears and Pros translocates from the GMC cell cortex into the
nucleus where it functions as a cell fate determinant. In the GMC,
Pros represses cell cycle and neuroblast genes and activates genes
required for neuronal differentiation (Choksi et al., 2006; Doe et al.
1991; Vaessin et al., 1991).
Although there are similarities between HAM-1 and Pros, un-
like Pros, HAM-1 also affects the positioning of the cleavage plane.
In wild type embryos, asymmetric division of the HSN/PHB neu-
roblast results in a smaller anterior daughter cell that undergoes
apoptosis and a larger posterior daughter cell. In a ham-1 null
mutant, the asymmetry in cell sizes is reversed, resulting in an
abnormally large apoptotic corpse. In ham-1 mutants embryos,
many additional abnormally large apoptotic cell corpses are ob-
served indicating that HAM-1 positions the cleavage plane in
many asymmetrically dividing cells (Frank et al., 2005). Post-
embryonically, ham-1 also affects the position of the cleavage
plane during the asymmetric division of Q.a (Feng et al., 2013). In
contrast to Pros, it has been argued that HAM-1 itself does not
behave as a cell fate determinant but instead affects the asym-
metric segregation of cell fate determinants (Frank et al., 2005;
Guenther and Garriga, 1996). Based on the fact that HAM-1 con-
tains a DNA binding domain, and GFP::HAM-1 localizes to the
nucleus, the possibility that HAM-1 functions as a cell fate de-
terminant must be re-evaluated.Funding
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